ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Final Issue of ‘78

December 15, 1978

Patients Report Clinical Trials Not Offered By Physician

June 27, 2008

IOM, NCI Clash Over Proposed Change in Tabulating Minority Research

January 22, 1999

Colorado Institutions Vying to Build First Carbon Ion Center in the U.S.

September 26, 2014

Advisors say NCI needs to reach out to other fields.

July 15, 2005

Reauthorization Battle Warms Up; Administration, But Not Wyngaarden, May OK Cancer Act Renewal

March 18, 1988